Skip to main content
CIN- L67120MH1995PLC084899


Generate password

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID



Beta Drugs Ltd.

NSE : BETAEQ BSE : ISIN CODE : INE351Y01019Industry : Pharmaceuticals

News

  • Beta Drugs - Investor Presentation 27 Jul 2026 | 21:24 | Dion Global

    Beta Drugs Limited has informed the Exchange about Investor Presentationmore...

  • Beta Drugs - Reply to Clarification- Financial results 23 Jul 2026 | 17:54 | Dion Global

    The Exchange had sought clarification from Beta Drugs Limited for the quarter ended 30-Jun-2026 with respect to Regulation 33 of the SEBI (L...more...

  • Beta Drugs - Clarification - Financial Results 22 Jul 2026 | 18:17 | Dion Global

    The Exchange has sought clarification from Beta Drugs Limited for the quarter ended 30-Jun-2026 with respect to Regulation 33 of the SEBI (Listing Ob...more...

  • Beta Drugs - Copy of Newspaper Publication 21 Jul 2026 | 11:58 | Dion Global

    Beta Drugs Limited has informed the Exchange about Copy of Newspaper Publicationmore...

  • Beta Drugs - Statement of deviation(s) or variation(s) under Reg. 32 20 Jul 2026 | 15:08 | Dion Global

    Beta Drugs Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32more...

  • Beta Drugs - Outcome of Board Meeting 20 Jul 2026 | 09:00 | Dion Global

    Beta Drugs Limited has submitted to the Exchange the financial results for the period ended Jun 30 2026.more...

  • Beta Drugs has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026 19 Jul 2026 | 14:00 | Dion Global

    As of June 2026 59.10% is owned by Indian Promoters and 40.90% by Public. Top five Promoters holding highest number of shares of Beta Drugs company a...more...

  • Beta Drugs - Certificate under SEBI (Depositories and Participants) Regulations, 2018 07 Jul 2026 | 10:44 | Dion Global

    Beta Drugs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018more...

  • Beta Drugs - Trading Window 30 Jun 2026 | 12:59 | Dion Global

    Beta Drugs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015more...

  • Beta Drugs - Spurt in Volume 15 Jun 2026 | 16:41 | Dion Global

    Significant increase in volume has been observed in Beta Drugs Limited. The Exchange in order to ensure that investors have latest relevant ...more...

  • Beta Drugs - Spurt in Volume 12 Jun 2026 | 18:21 | Dion Global

    Significant increase in volume has been observed in Beta Drugs Limited. The Exchange in order to ensure that investors have latest relevant informati...more...

  • Beta Drugs has submitted to BSE the Shareholding Pattern for the Period Ended May 25, 2026 12 Jun 2026 | 11:50 | Dion Global

    As of May 2026 59.10% is owned by Indian Promoters and 40.90% by Public. Top five Promoters holding highest number of shares of Beta Drugs c...more...

  • Beta Drugs - General Updates 25 May 2026 | 20:20 | Dion Global

    Beta Drugs Limited has informed the Exchange about Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulatio...more...

  • Beta Drugs - Outcome of Board Meeting 25 May 2026 | 12:10 | Dion Global

    Beta Drugs Limited has informed the Exchange regarding Outcome of Board Meeting held on May 25 2026.more...

  • Beta Drugs - Analysts/Institutional Investor Meet/Con. Call Updates 22 May 2026 | 20:27 | Dion Global

    Beta Drugs Limited has informed the Exchange about Transcriptmore...

  • Beta Drugs - Copy of Newspaper Publication 16 May 2026 | 11:22 | Dion Global

    Beta Drugs Limited has informed the Exchange about Copy of Newspaper Publicationmore...

  • Beta Drugs - Analysts/Institutional Investor Meet/Con. Call Updates 15 May 2026 | 16:58 | Dion Global

    Beta Drugs Limited has informed the Exchange about Link of Recordingmore...

  • Beta Drugs - Analysts/Institutional Investor Meet/Con. Call Updates 15 May 2026 | 08:41 | Dion Global

    Beta Drugs Limited has informed the Exchange about Presentationmore...

  • Beta Drugs Q4 net profit zooms 283.45% at Rs 5.33 cr 14 May 2026 | 17:30 | Dion Global

    The company reported standalone net profit of Rs 5.33 crore for the quarter ended March 31 2026 as compared to Rs 1.39 crore in the same period last ...more...

  • Beta Drugs - Statement of deviation(s) or variation(s) under Reg. 32 14 May 2026 | 16:43 | Dion Global

    Beta Drugs Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32more...

DOW Jones45473.550.16%
Nasdaq21794.160.43%
S&P 5006496.040.22%
Nikkei 22543643.811.45%
Hang Seng25633.910.85%
Shanghai Composite3826.840.38%
Sensex78499.17-0.58%
NSE Index24570.65-0.26%
B500DIVL503610.360.20%
BSE 1000 11106.65-0.19%
BSE 100LCTMC9269.55-0.36%
BSE Auto 65073.811.33%

Commodity

Gold1491970.82%
Silver2321872.89%
Copper1396.3242.40%
Crude Oil735814.74%
Lead209.455.80%
Mentha Oil1331.324.72%
Nickel1651.8115.39%

Currency

USD/INR 95.21(0.00 %)
GBP/INR 128.12(-0.03 %)
EUR/INR 109.72(-0.20 %)
JPY/INR 0.60(-0.57 %)
CAD/INR 67.90(0.00 %)
HKD/INR 12.13(0.01 %)